cbdMD, Inc. (NYSEAM: YCBD)
Health Care · Pharmaceuticals · US
$0.52
+1.79% today · -27.8% 1Y
cbdMD, Inc. (NYSEAM: YCBD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.70M and employs 42 people.
Over the last twelve months the share price has lost 27.8%, trading between 0.47 and 2.56.
Tweenvest scores cbdMD, Inc. across four factors: quality 37/100, value 71/100, growth 0/100. Its strongest factor is value.
YCBD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.70M
- Revenue (TTM)
- $20.93M
- P/E
- —
- EPS
- -0.32
- Dividend yield
- —
- Beta (5Y)
- 2.17
- 52-week high
- $2.56
- 52-week low
- $0.47
- Avg volume (3M)
- —
- Shares outstanding
- 11.21M
- Employees
- 42
- Next earnings
- —
About cbdMD, Inc.
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
- ISIN
- US12482W4087
- Listed since
- Nov 17, 2017
- Exchange
- NYSE American LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.